Dr. Zahra Natik Turki (1), Dr. Adeebah Abd Mahdi Alselawi (2), Dr. Sadiq Jafar Murtadha Jafar (3)
Background: Viral infections of the skin are frequent in children, which is often painful and impacts their lives where in paper examines their clinical manifestations, diagnosis, treatment and health outcomes in general where collected One hundred fifteen children aged 0-18 years having their viral skin infections confirmed by laboratory were enrolled while according to The data collection involved questionnaires, physical examination and laboratory tests. We have examined the demographics of patients, the severity of so based on our finding were symptoms, the future result of treatment, and complications as well as Varicella -Zoster virus and Human Papillomavirus 26.1 and Herpes Simplex 21.7 (39.1) also found in results The majority of the children (87.0%), had a rash; 43.5% followed by 60.9 percent had a fever and itchy respectively furthermore in finding Clinical assessment and PCR testing were mostly used to make diagnoses in addition to as The treatment were categorized into antiviral (26.1%), topical (43.5) and supportive care even can The infections led to a total of 250 days of absenteeism, which highlights the importance of this aspect in the context of the public health.
Conclusion: Childhood viral skin infections have different manifestations and may cause severe health consequences. Precise diagnosis and early and proper treatment are necessary to enhance outcomes and minimize the effects on normal day-to-day living. The paper also emphasizes the role of vaccination and community education to reduce the rates of infection and morbidity.
1. Hayden GF. Skin diseases encountered in a pediatric clinic. A one-year prospective study. Am J Dis Childhood 1985;139: 36-8. [DOI] [PubMed] [Google Scholar]
2. Tunnessen WW. A survey of skin disorders seen in pediatric general and dermatology clinics. Pediatr Dermatol 1984;1: 219-22. [DOI] [PubMed] [Google Scholar]
3. Findlay GH, Vismer HF, Sophianos T. The spectrum of pediatric dermatology. Analysis of 10,000 cases. Br J Dermatol 1974;91: 379-87. [DOI] [PubMed] [Google Scholar]
4. Rogers M, Barnetson RSC. Diseases of the skin. In: Campbell AGM, McIntosh N, eds. Forfar and Arneil's textbook of pediatrics. 5th ed. New York: Churchill Livingstone, 1998: 1633-5.
5. Koning S, Bruijnzeels MA, van Suijlekom-Smit LWA, van der Wouden JC. Molluscum contagiosum in Dutch general practice. Br J Gen Pract 1994;44: 417-9. [PMC free article] [PubMed] [Google Scholar]
6. Weller R, O'Callaghan CJ, MacSween RM, White MI. Scarring in molluscum contagiosum: comparison of physical expression and phenol ablation. BMJ 1999;319: 1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
7. Van der Wouden JC, Gajadin S, Berger MY, Butler CC, Koning S, Menke J, et al. Interventions for molluscum contagiosum in children. Cochrane Library: 2004, Issue 2. Chichester: Wiley.
8. Cabanillas B, Novak N. Atopic dermatitis and filaggrin. Curr Opin Immunol. (2016) 42:1–8. 10.1016/j.coi.2016.05.002 [DOI] [PubMed] [Google Scholar]
9. Furue M. Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis. Int J Mol Sci. (2020) 21 (15):5382. 10.3390/ijms21155382 [DOI] [PMC free article] [PubMed] [Google Scholar]
10. Lopes C, Rocha L, Sokhatska O, Soares J, Tavaria F, Correia O, et al. Filaggrin polymorphism Pro478Ser is associated with the severity of atopic dermatitis and colonization by Staphylococcus aureus. J Investig Allergol Clin Immunol. (2016) 26 (1):70–2. 10.18176/jiaci.0017 [DOI] [PubMed] [Google Scholar]
11. Wolk K, Mitsui H, Witte K, Gellrich S, Gulati N, Humme D, et al. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function. Clin Cancer Res. (2014) 20 (21):5507–16. 10.1158/1078-0432.CCR-14-0707 [DOI] [PubMed] [Google Scholar]
12. Hata TR, Gallo RL. Antimicrobial peptides, skin infections, and atopic dermatitis. Semin Cutan Med Surg. (2008) 27 (2):144–50. 10.1016/j.sder.2008.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
13. Langan SM, Abuabara K, Henrickson SE, Hoffstad O, Margolis DJ. Increased risk of cutaneous and systemic infections in atopic dermatitis—a cohort study. J Invest Dermatol. (2017) 137 (6):1375–7. 10.1016/j.jid.2017.01.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
14. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. (2002) 347 (15):1151–60. 10.1056/NEJMoa021481 [DOI] [PubMed] [Google Scholar]
15. Kasperkiewicz M, Schmidt E, Ludwig RJ, Zillikens D. Targeting IgE antibodies by immunoadsorption in atopic dermatitis. Front Immunol. (2018) 9:254. 10.3389/fimmu.2018.00254 [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Wollenberg A, Thomsen SF, Lacour JP, Jaumont X, Lazarewicz S. Targeting immunoglobulin E in atopic dermatitis: a review of the existing evidence. World Allergy Organ J. (2021) 14 (3):100519. 10.1016/j.waojou.2021.100519 [DOI] [PMC free article] [PubMed] [Google Scholar]
17. Holm JG, Agner T, Clausen ML, Thomsen SF. Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march. Arch Dermatol Res. (2019) 311 (3):173–82. 10.1007/s00403-019-01895-z [DOI] [PubMed] [Google Scholar]
18. Jinnestal CL, Belfrage E, Back O, Sonesson A. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol. (2014) 53 (1):27–33. 10.1111/ijd.12198 [DOI] [PubMed] [Google Scholar]
19. Mack MR, Brestoff JR, Berrien-Elliott MM, Trier AM, Yang TB, McCullen M. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Sci Transl Med. (2020) 12 (532):eaay1005. 10.1126/scitranslmed.aay1005 [DOI] [PMC free article] [PubMed] [Google Scholar]
20. Leyva-Castillo JM, Hener P, Michea P, Karasuyama H, Chan S, Soumelis V, et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun. (2013) 4:2847. 10.1038/ncomms3847 [DOI] [PubMed] [Google Scholar]